Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

Ultrasound is already used for diagnosis and therapy. Recent studies have found it also to be a safe, effective, and rapid ...

SALT LAKE CITY, Utah. (Ivanhoe Newswire) - Chronic pain and treatment-resistant depression both impact millions of people. Both can be debilitating and both can leave people feeling hopeless, ...

“Electroshock” or electroconvulsive therapy. The existing treatment options for those diagnosed with Major Depressive ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...

Around 63% of these participants had been classed with having treatment-resistant depression. Half the participants received ...